Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
4
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
4
×
new york top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
aducanumab
alzheimer's disease
cancer
clinical trials
crispr
digital health
fda
gene therapy
gilead sciences
What
new
4
×
bio
roundup
ipo
medicines
remains
activity
aims
allogene
approval
approvals
backed
biogen
biogen’s
biopharmaceutical
cancer
cause
ceo
clamped
companies
convo
covid
crispr
delays
developing
diversity
drug
drugs
earlier
economic
epilepsy
failures
fast
fda
genes
genetic
hot
immunotherapy
including
investors
Language
unset
Current search:
biogen
×
new
×
" new york blog main "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More